$601.03
8.991.52%
In chiusura: Nov 26, 4:00 PM EST
$601.03
N/A
After hour: 4:00 PM EST
Comments
Loading...
Stime degli utili, EPS e fatturato
Madrigal Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
feb 25
Stima EPS
$0.180
Stima dei ricavi trimestrali
$310.09M
Ricavi annuali
(a partire da set 30)
(a partire da set 30)
$740.64M
Analizza lo storico degli utili di Madrigal Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
MDGL | Madrigal Pharmaceuticals | -$2.71 | $0.18 | — | — | $103.32M | $310.09M | — | — | 02/25/2026 | |
MDGL | Madrigal Pharmaceuticals | -$4.92 | -$1.99 | -$5.08 | -155.28% | $62.17M | $247.20M | $287.27M | 16.21% | 11/04/2025 | |
MDGL | Madrigal Pharmaceuticals | -$7.10 | -$3.52 | -$1.90 | 46.02% | $14.64M | $161.32M | $212.80M | 31.91% | 08/05/2025 | |
MDGL | Madrigal Pharmaceuticals | -$7.38 | -$3.79 | -$3.32 | 12.40% | $0.00 | $114.19M | $137.25M | 20.19% | 05/01/2025 | |
MDGL | Madrigal Pharmaceuticals | -$5.68 | -$4.12 | -$2.71 | 34.22% | $0.00 | $91.25M | $103.32M | 13.23% | 02/26/2025 | |
MDGL | Madrigal Pharmaceuticals | -$5.34 | -$6.91 | -$4.92 | 28.80% | $0.00 | $34.19M | $62.17M | 81.85% | 10/31/2024 | |
MDGL | Madrigal Pharmaceuticals | -$4.69 | -$7.54 | -$7.10 | 5.84% | $0.00 | $4.02M | $14.64M | 264.13% | 08/07/2024 | |
MDGL | Madrigal Pharmaceuticals | -$4.23 | -$6.28 | -$7.38 | -17.52% | $0.00 | — | $0.00 | — | 05/07/2024 | |
MDGL | Madrigal Pharmaceuticals | -$4.98 | -$5.28 | -$5.68 | -7.58% | $0.00 | — | $0.00 | — | 02/28/2024 | |
MDGL | Madrigal Pharmaceuticals | -$4.75 | -$4.92 | -$5.34 | -8.54% | $0.00 | — | $0.00 | — | 11/06/2023 | |
MDGL | Madrigal Pharmaceuticals | -$4.14 | -$4.58 | -$4.69 | -2.40% | $0.00 | — | $0.00 | — | 08/08/2023 | |
MDGL | Madrigal Pharmaceuticals | -$3.36 | -$4.94 | -$4.23 | 14.37% | $0.00 | — | $0.00 | — | 05/09/2023 | |
MDGL | Madrigal Pharmaceuticals | -$3.78 | -$4.56 | -$4.98 | -9.21% | $0.00 | — | $0.00 | — | 02/23/2023 | |
MDGL | Madrigal Pharmaceuticals | -$3.79 | -$4.15 | -$4.75 | -14.46% | $0.00 | — | $0.00 | — | 11/03/2022 | |
MDGL | Madrigal Pharmaceuticals | -$3.72 | -$3.75 | -$4.14 | -10.40% | $0.00 | — | $0.00 | — | 08/04/2022 | |
MDGL | Madrigal Pharmaceuticals | -$3.32 | -$3.62 | -$3.36 | 7.18% | $0.00 | — | $0.00 | — | 05/09/2022 | |
MDGL | Madrigal Pharmaceuticals | -$3.82 | -$3.88 | -$3.78 | 2.58% | $0.00 | — | $0.00 | — | 02/24/2022 | |
MDGL | Madrigal Pharmaceuticals | -$3.75 | -$3.90 | -$3.79 | 2.82% | $0.00 | — | $0.00 | — | 11/04/2021 | |
MDGL | Madrigal Pharmaceuticals | -$3.18 | -$3.59 | -$3.72 | -3.62% | $0.00 | — | $0.00 | — | 08/05/2021 | |
MDGL | Madrigal Pharmaceuticals | -$2.34 | -$3.85 | -$3.32 | 13.77% | $0.00 | — | $0.00 | — | 05/06/2021 | |
MDGL | Madrigal Pharmaceuticals | -$1.80 | — | -$3.82 | — | $0.00 | — | $0.00 | — | 02/25/2021 |
Madrigal Pharmaceuticals (MDGL) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $-5.08 | $-1.99 | -155.3 % |
| Q2 | 2025-08-05 | $-1.90 | $-3.52 | 46.0 % |
| Q1 | 2025-05-01 | $-3.32 | $-3.79 | 12.4 % |
| Q4 | 2025-02-26 | $-2.71 | $-4.12 | 34.2 % |
Madrigal Pharmaceuticals (MDGL) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $287.27M | $247.20M | 16.2 % |
| Q2 | 2025-08-05 | $212.80M | $161.32M | 31.9 % |
| Q1 | 2025-05-01 | $137.25M | $114.19M | 20.2 % |
| Q4 | 2025-02-26 | $103.32M | $91.25M | 13.2 % |
FAQ
Quando Madrigal Pharmaceuticals (NASDAQ:MDGL) riporterà gli utili?
Si prevede che Madrigal Pharmaceuticals (MDGL) fornisca risultati il febbraio 25, 2026. Gli ultimi risultati sono stati pubblicati il novembre 4, 2025 per il Q3.
Quali sono stati gli ultimi utili per azione (EPS) di Madrigal Pharmaceuticals (NASDAQ:MDGL)?
L'EPS effettivo era $-5.08, che mancato la stima di $-1.99.
Quali sono state le entrate di Madrigal Pharmaceuticals (NASDAQ:MDGL)?
Le entrate effettive sono state $287.3M, che superato la stima di $247.2M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.